Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.

<h4>Background</h4>Rates of oropharyngeal cancer (OPC) associated with alcohol & tobacco use have decreased, while human papillomavirus (HPV) associated OPC has increased among men in the US. Secretory leukocyte protease inhibitor (SLPI), detectable in a variety of secretions, has be...

Full description

Bibliographic Details
Main Authors: Brittney L Dickey, Bradley Sirak, Laura Martin-Gomez, Richard R Reich, Martha Abrahamsen, Kimberly Isaacs-Soriano, Christine H Chung, Anna R Giuliano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0254161

Internet

https://doi.org/10.1371/journal.pone.0254161

Similar Items